1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
2.2. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Drug, 2023 (US$ Million)
2.3. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Infection, 2023 (US$ Million)
2.4. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Pathogen, 2023 (US$ Million)
2.5. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Vendors
3.2. Strategies Adopted by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Vendors
3.3. Key Industry Strategies
4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Delafloxacin
5.3.2. Vancomycin
5.3.3. Ceftaroline fosamil
5.3.4. Telvancin
5.3.5. Oritavancin
5.3.6. Tedizolid
5.3.7. Daptomycin
5.3.8. Tigecycline
5.3.9. Linezolid
5.3.10. TMP-SMZ
5.3.11. Others (Doxycycline, Levofloxacin, Metronidazole, and Others)

6. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Cellulitis
6.3.2. Abscess/Boil/Cyst
6.3.3. Surgical Wound
6.3.4. Traumatic Wound

7. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Methicillin sensitive Staphylococcus aureus (MSSA)
7.3.2. Methicillin resistant Staphylococcus aureus (MRSA)
7.3.3. Beta-hemolytic Streptococcus
7.3.4. Escherichia coli
7.3.5. Enterococcus faecalis
7.3.6. Pseudomonas aeruginosa
7.3.7. Others


8. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
8.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
8.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
8.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
8.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
8.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
8.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
8.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
8.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
8.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)

9. UK and European Union Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
9.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
9.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
9.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
9.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
9.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
9.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
9.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
9.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
9.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
9.5.1.4.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
9.5.1.4.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
9.5.1.5.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
9.5.1.5.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
9.5.1.6.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
9.5.1.6.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)

10. Asia Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
10.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
10.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
10.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
10.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
10.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
10.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
10.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
10.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
10.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
10.5.1.4.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
10.5.1.4.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
10.5.1.5.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
10.5.1.5.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
10.5.1.6.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
10.5.1.6.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)

11. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
11.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
11.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
11.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
11.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
11.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
11.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
11.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
11.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
11.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)

12. Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
12.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
12.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
12.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
12.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
12.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
12.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
12.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2022-2032, USD (Million)
12.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2022-2032, USD (Million)
12.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2022-2032, USD (Million)

13. Company Profile
13.1. Furiex Pharmaceuticals, Inc.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. GlaxoSmithKline plc
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Melinta Therapeutics, Inc.
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Debiopharm International S.A.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. MerLion Pharmaceuticals Pte Ltd.
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Durata Therapeutics, Inc.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Paratek Pharmaceuticals, Inc.
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Cempra, Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Abbott Laboratories, Inc.
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Actelion Pharmaceuticals Ltd.
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Albany Molecular Research, Inc.
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Allergan plc.
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. AstraZeneca
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. Bayer AG
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives
13.15. Macrolide Pharmaceuticals, Inc.
13.15.1. Company Overview
13.15.2. Financial Performance
13.15.3. Product Portfolio
13.15.4. Strategic Initiatives
13.16. Merck & Co, Inc.
13.16.1. Company Overview
13.16.2. Financial Performance
13.16.3. Product Portfolio
13.16.4. Strategic Initiatives
13.17. Pfizer, Inc.
13.17.1. Company Overview
13.17.2. Financial Performance
13.17.3. Product Portfolio
13.17.4. Strategic Initiatives
13.18. Sanofi
13.18.1. Company Overview
13.18.2. Financial Performance
13.18.3. Product Portfolio
13.18.4. Strategic Initiatives
13.19. Teva Pharmaceuticals Industries Ltd.
13.19.1. Company Overview
13.19.2. Financial Performance
13.19.3. Product Portfolio
13.19.4. Strategic Initiatives
13.20. Zavante Therapeutics, Inc.
13.20.1. Company Overview
13.20.2. Financial Performance
13.20.3. Product Portfolio
13.20.4. Strategic Initiatives